Max Lange
Overview
Explore the profile of Max Lange including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
393
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mollenhauer M, Mehrkens D, Klinke A, Lange M, Remane L, Friedrichs K, et al.
Sci Rep
. 2020 Sep;
10(1):15319.
PMID: 32948795
Nitro-fatty acids are electrophilic anti-inflammatory mediators which are generated during myocardial ischemic injury. Whether these species exert anti-arrhythmic effects in the acute phase of myocardial ischemia has not been investigated...
2.
Haas K, Stangl S, Steigerwald F, Matthies C, Gruber D, Kuhn A, et al.
Parkinsonism Relat Disord
. 2019 Feb;
60:3-9.
PMID: 30772278
Introduction: Deep Brain Stimulation (DBS) is a complex, invasive and cost-intensive therapy that requires a high level of expertise. To date, data on quality of DBS in clinical routine in...
3.
Zech N, Seemann M, Seyfried T, Lange M, Schlaier J, Hansen E
Stereotact Funct Neurosurg
. 2018 Dec;
96(6):370-378.
PMID: 30517938
Background: Sedatives and opioids used during deep brain stimulation (DBS) surgery interfere with optimal target localization and add to side effects and risks, and thus should be minimized. Objective: To...
4.
Anthofer J, Herbst A, Janzen A, Lange M, Brawanski A, Schlaier J
Acta Neurochir (Wien)
. 2017 Nov;
160(2):385-387.
PMID: 29116383
Deep brain stimulation for Parkinson's disease has become an established treatment option in recent years. The method and its application in clinical practice has proved to be safe and effective....
5.
Blume J, Rothenfusser E, Schlaier J, Bogdahn U, Lange M
J Neurol Sci
. 2017 Oct;
381:141-143.
PMID: 28991666
Objective: To explore the relationship of motor burden and educational attainment in patients with advanced stage PD. Materials And Methods: We included 102 consecutive patients who underwent a complete evaluation...
6.
Mollenhauer M, Friedrichs K, Lange M, Gesenberg J, Remane L, Kerkenpass C, et al.
Circ Res
. 2017 Apr;
121(1):56-70.
PMID: 28404615
Rationale: Ventricular arrhythmias remain the leading cause of death in patients suffering myocardial ischemia. Myeloperoxidase, a heme enzyme released by polymorphonuclear neutrophils, accumulates within ischemic myocardium and has been linked...
7.
Schlaier J, Beer A, Faltermeier R, Fellner C, Steib K, Lange M, et al.
Eur J Neurosci
. 2017 Apr;
45(12):1623-1633.
PMID: 28391647
This study compared tractography approaches for identifying cerebellar-thalamic fiber bundles relevant to planning target sites for deep brain stimulation (DBS). In particular, probabilistic and deterministic tracking of the dentate-rubro-thalamic tract...
8.
Anthofer J, Steib K, Lange M, Rothenfusser E, Fellner C, Brawanski A, et al.
J Neurol Surg A Cent Eur Neurosurg
. 2017 Mar;
78(4):350-357.
PMID: 28320027
Some patients under thalamic deep brain stimulation (DBS) for essential tremor (ET) experience habituation of tremor reduction. The nucleus ventralis intermedius (Vim) is the current main target side for ET...
9.
Lange M, Mauerer J, Schlaier J, Janzen A, Zeman F, Bogdahn U, et al.
Acta Neurochir (Wien)
. 2017 Mar;
159(5):771-778.
PMID: 28258308
Background: Only 10% of the up to 15% of patients with advanced Parkinson's disease (PD) eligible for deep brain stimulation (DBS) are referred to specialized centers. This survey evaluated the...
10.
Hohne J, Schebesch K, Ott C, Brawanski A, Lange M
J Neurosurg Sci
. 2016 Nov;
62(4):418-422.
PMID: 27854111
Background: Perioperative seizure prophylaxis with antiepileptic drugs (AED) has been advocated in patients undergoing supratentorial craniotomy. The practice remains controversial. The reasoning presupposes that the possibility of an adverse drug...